DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.06 Bil PE Ratio: 48.19 PB Ratio: 15.88 GF Score: 74/100

Q1 2022 Dexcom Inc Earnings Call Transcript

Apr 28, 2022 / 09:30PM GMT
Release Date Price: R$10.18 (-1.28%)
Operator

(Operator Instructions) As a reminder, today's conference is being recorded.

I will now turn the call over to Mr. Kevin Sayer. Sir, you may begin.

Kevin Ronald Sayer
DexCom, Inc. - Executive Chairman, CEO & President

Thank you, operator. We apologize for being a bit late today. We've had some difficulties with our conference call service provider here, but we're up and running now. And we're excited to talk about a good quarter.

I'm going to turn it over to Sean. Sean?

Sean Christensen
DexCom, Inc. - Director of Corporate Affairs & Head of IR

Thank you, and welcome to Dexcom's First Quarter 2022 Earnings Call. Our agenda begins with Kevin Sayer, Dexcom's Chairman, President and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer.

Following our prepared remarks, we will open the call up for your questions. (Operator Instructions) Please note that there are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot